Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ISRCTN15690435) titled 'Artificial intelligence to predict cardiovascular risk recurrence in people with type 2 diabetes' on April 23.
Study Type: Observational
Study Design:
Cohort study
Primary Sponsor: Navarre Health Research Institute Foundation (IDISNA)
Condition:
Type 2 diabetes mellitus and cardiovascular disease (secondary prevention of cardiovascular events)
Nutritional, Metabolic, Endocrine
Intervention:
Observational study with no intervention. Data collection only, including clinical, biological and wearable-derived variables.
A total of 250 patients aged 40-70 years will be recruited from hospital and primary care sett...